Humanized antibodies that recognize beta amyloid peptide
US7625560B2 · kind B2 · utility
55Cited by
169References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 15, 2005 |
| Grant date | Dec 1, 2009 |
| Priority date | — |
| Expiry date | Apr 22, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of Aβ in the brain of a patient. Preferred agents include antibodies, e.g., humanized antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.